Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Angiography | 38 | 2023 | 4451 | 1.740 |
Why?
|
Coronary Stenosis | 16 | 2022 | 793 | 1.560 |
Why?
|
Coronary Artery Disease | 36 | 2024 | 6362 | 1.530 |
Why?
|
Plaque, Atherosclerotic | 20 | 2024 | 1505 | 1.350 |
Why?
|
Chest Pain | 15 | 2022 | 1090 | 1.080 |
Why?
|
Acute Coronary Syndrome | 17 | 2024 | 2180 | 1.000 |
Why?
|
Coronary Vessels | 12 | 2023 | 3072 | 0.750 |
Why?
|
Diagnosis | 2 | 2017 | 156 | 0.670 |
Why?
|
Therapeutics | 1 | 2017 | 113 | 0.580 |
Why?
|
Angina Pectoris | 5 | 2019 | 958 | 0.540 |
Why?
|
Ebolavirus | 1 | 2017 | 251 | 0.480 |
Why?
|
Risk | 2 | 2017 | 9599 | 0.440 |
Why?
|
Probability | 1 | 2017 | 2467 | 0.410 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 420 | 0.400 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2024 | 3227 | 0.380 |
Why?
|
Troponin I | 4 | 2022 | 632 | 0.380 |
Why?
|
Models, Theoretical | 5 | 2020 | 3561 | 0.350 |
Why?
|
Tomography, X-Ray Computed | 17 | 2023 | 20500 | 0.320 |
Why?
|
Predictive Value of Tests | 25 | 2023 | 15225 | 0.320 |
Why?
|
Risk Assessment | 26 | 2023 | 23884 | 0.310 |
Why?
|
Managed Competition | 1 | 2006 | 32 | 0.270 |
Why?
|
Exercise Test | 3 | 2020 | 2121 | 0.270 |
Why?
|
Cardiovascular Diseases | 8 | 2024 | 15399 | 0.260 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2020 | 317 | 0.260 |
Why?
|
Models, Economic | 2 | 2019 | 715 | 0.230 |
Why?
|
Radiography, Thoracic | 2 | 2021 | 1296 | 0.220 |
Why?
|
Myocardial Infarction | 7 | 2022 | 11424 | 0.220 |
Why?
|
HIV Infections | 7 | 2024 | 17275 | 0.220 |
Why?
|
Troponin | 2 | 2024 | 500 | 0.210 |
Why?
|
National Health Programs | 1 | 2006 | 441 | 0.210 |
Why?
|
Financing, Government | 1 | 2006 | 472 | 0.210 |
Why?
|
Risk Adjustment | 1 | 2006 | 600 | 0.210 |
Why?
|
Myocardial Revascularization | 3 | 2020 | 792 | 0.200 |
Why?
|
Middle Aged | 55 | 2024 | 219568 | 0.200 |
Why?
|
Atherosclerosis | 3 | 2023 | 3401 | 0.200 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2019 | 139 | 0.180 |
Why?
|
Decision Making | 2 | 2015 | 3915 | 0.180 |
Why?
|
Prognosis | 18 | 2023 | 29557 | 0.180 |
Why?
|
Cardiac Volume | 1 | 2021 | 199 | 0.180 |
Why?
|
Adipose Tissue | 4 | 2023 | 3299 | 0.180 |
Why?
|
Risk Factors | 27 | 2023 | 73809 | 0.170 |
Why?
|
Male | 59 | 2024 | 358747 | 0.170 |
Why?
|
Female | 57 | 2024 | 390323 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 759 | 0.160 |
Why?
|
Pericardium | 2 | 2020 | 674 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 239 | 0.140 |
Why?
|
Echocardiography, Stress | 1 | 2017 | 134 | 0.140 |
Why?
|
Prospective Studies | 18 | 2024 | 54137 | 0.140 |
Why?
|
Humans | 69 | 2024 | 758406 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 831 | 0.130 |
Why?
|
Coronary Care Units | 1 | 2016 | 235 | 0.120 |
Why?
|
Logic | 1 | 2015 | 40 | 0.120 |
Why?
|
Aged | 27 | 2024 | 168218 | 0.110 |
Why?
|
Contrast Media | 3 | 2023 | 5298 | 0.110 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14641 | 0.110 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 1993 | 44 | 0.110 |
Why?
|
Aspirin | 2 | 2015 | 3131 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2017 | 939 | 0.110 |
Why?
|
Calcium | 5 | 2023 | 5721 | 0.100 |
Why?
|
Brain Injuries | 1 | 2024 | 2044 | 0.100 |
Why?
|
Cholelithiasis | 1 | 1993 | 407 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 36284 | 0.100 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 1993 | 231 | 0.090 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 872 | 0.090 |
Why?
|
Electrocardiography | 4 | 2017 | 6363 | 0.090 |
Why?
|
Rupture, Spontaneous | 3 | 2018 | 353 | 0.090 |
Why?
|
Cholecystectomy | 1 | 1993 | 406 | 0.090 |
Why?
|
Gallstones | 1 | 1993 | 283 | 0.090 |
Why?
|
Severity of Illness Index | 9 | 2019 | 15785 | 0.090 |
Why?
|
Emergency Service, Hospital | 4 | 2019 | 7810 | 0.090 |
Why?
|
Reproducibility of Results | 9 | 2021 | 20055 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2886 | 0.090 |
Why?
|
Troponin T | 1 | 2015 | 761 | 0.090 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 1991 | 92 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2015 | 1177 | 0.080 |
Why?
|
Triage | 1 | 2016 | 986 | 0.080 |
Why?
|
Evidence-Based Medicine | 3 | 2018 | 3671 | 0.080 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2015 | 570 | 0.080 |
Why?
|
Dyspnea | 1 | 2017 | 1344 | 0.080 |
Why?
|
Intraoperative Care | 1 | 1993 | 766 | 0.080 |
Why?
|
Colonic Diseases | 1 | 1991 | 200 | 0.080 |
Why?
|
Lung Diseases | 1 | 2019 | 1910 | 0.080 |
Why?
|
Cardiology | 2 | 2024 | 1667 | 0.080 |
Why?
|
Intestinal Perforation | 1 | 1991 | 249 | 0.080 |
Why?
|
Health Care Costs | 2 | 2019 | 3245 | 0.080 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2023 | 1214 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1755 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2020 | 3806 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 787 | 0.070 |
Why?
|
Asymptomatic Diseases | 2 | 2021 | 584 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 2015 | 1554 | 0.070 |
Why?
|
Markov Chains | 2 | 2020 | 965 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2015 | 2747 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1668 | 0.070 |
Why?
|
HIV | 2 | 2023 | 1581 | 0.070 |
Why?
|
Models, Statistical | 1 | 2020 | 5070 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3211 | 0.070 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 1097 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1415 | 0.060 |
Why?
|
North America | 2 | 2019 | 1276 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2024 | 80168 | 0.060 |
Why?
|
Germany | 1 | 2006 | 868 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2500 | 0.060 |
Why?
|
Cost Control | 1 | 2006 | 628 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8945 | 0.060 |
Why?
|
Automation | 2 | 2017 | 580 | 0.060 |
Why?
|
Smoking | 1 | 2020 | 9051 | 0.060 |
Why?
|
ROC Curve | 3 | 2015 | 3563 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12096 | 0.050 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 715 | 0.050 |
Why?
|
Iohexol | 1 | 2023 | 204 | 0.050 |
Why?
|
Cohort Studies | 6 | 2022 | 41256 | 0.050 |
Why?
|
Disease Progression | 4 | 2021 | 13468 | 0.050 |
Why?
|
Public Policy | 1 | 2006 | 559 | 0.050 |
Why?
|
Time Factors | 6 | 2020 | 39872 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9985 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2782 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 11336 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 10146 | 0.050 |
Why?
|
Area Under Curve | 2 | 2015 | 1632 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 640 | 0.050 |
Why?
|
Observer Variation | 2 | 2018 | 2600 | 0.050 |
Why?
|
Prevalence | 4 | 2019 | 15651 | 0.040 |
Why?
|
Biliary Fistula | 1 | 1999 | 37 | 0.040 |
Why?
|
Decision Support Techniques | 2 | 2020 | 1996 | 0.040 |
Why?
|
Health Policy | 2 | 2015 | 2677 | 0.040 |
Why?
|
Bronchial Fistula | 1 | 1999 | 83 | 0.040 |
Why?
|
Inflammation | 3 | 2024 | 10718 | 0.040 |
Why?
|
Spinal Diseases | 1 | 2024 | 559 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 755 | 0.040 |
Why?
|
Adult | 11 | 2024 | 219935 | 0.040 |
Why?
|
Infant, Premature, Diseases | 1 | 2024 | 708 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1125 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4580 | 0.040 |
Why?
|
United States | 7 | 2019 | 72136 | 0.040 |
Why?
|
Health Care Reform | 1 | 2006 | 1245 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12951 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5484 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6493 | 0.030 |
Why?
|
Acute Disease | 2 | 2017 | 7225 | 0.030 |
Why?
|
Hospitalization | 4 | 2017 | 10652 | 0.030 |
Why?
|
Hepatectomy | 1 | 1999 | 559 | 0.030 |
Why?
|
Thorax | 1 | 2019 | 553 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2019 | 5199 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13245 | 0.030 |
Why?
|
Artifacts | 1 | 2024 | 1897 | 0.030 |
Why?
|
Boston | 2 | 2020 | 9304 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39059 | 0.030 |
Why?
|
Gestational Age | 1 | 2024 | 3565 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2024 | 1868 | 0.030 |
Why?
|
Infant, Premature | 1 | 2024 | 2092 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9650 | 0.030 |
Why?
|
Registries | 2 | 2022 | 8175 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4244 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 918 | 0.030 |
Why?
|
Duodenoscopy | 1 | 1993 | 45 | 0.030 |
Why?
|
Sex Factors | 2 | 2017 | 10504 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1705 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2017 | 887 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1016 | 0.030 |
Why?
|
Duodenoscopes | 1 | 1993 | 43 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1503 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12440 | 0.030 |
Why?
|
Electrocoagulation | 1 | 1993 | 152 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21272 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1722 | 0.030 |
Why?
|
Software | 2 | 2017 | 4415 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1206 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3208 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1870 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22032 | 0.020 |
Why?
|
Models, Psychological | 1 | 2015 | 830 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2024 | 3339 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13276 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3425 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2023 | 2002 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4540 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1256 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2018 | 1489 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2751 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 1066 | 0.020 |
Why?
|
Gadolinium | 1 | 2015 | 959 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2023 | 58683 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1858 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12262 | 0.020 |
Why?
|
American Heart Association | 1 | 2014 | 1039 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3816 | 0.020 |
Why?
|
Coronary Circulation | 1 | 2015 | 1561 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2015 | 1474 | 0.020 |
Why?
|
Postoperative Complications | 1 | 1991 | 15637 | 0.020 |
Why?
|
Patient Admission | 1 | 2015 | 1372 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7378 | 0.020 |
Why?
|
Primary Prevention | 1 | 2015 | 1185 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 2108 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6821 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2014 | 1956 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6293 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2215 | 0.010 |
Why?
|
Survivors | 1 | 2015 | 2370 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2017 | 3047 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26183 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10748 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5427 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7985 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16534 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10495 | 0.010 |
Why?
|
Colon | 1 | 1991 | 1787 | 0.010 |
Why?
|
Echocardiography | 1 | 2015 | 4962 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3891 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3433 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5331 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18358 | 0.010 |
Why?
|
Cholangiography | 1 | 1999 | 181 | 0.010 |
Why?
|
Recurrence | 1 | 1991 | 8426 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13285 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1999 | 506 | 0.010 |
Why?
|
Stroke | 1 | 2017 | 9694 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25956 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13961 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64378 | 0.010 |
Why?
|
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_